StockData
Interpace Biosciences, Inc. logo

Interpace Biosciences, Inc. (IDXG) stock

IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)

Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –

Interpace Biosciences gross margin

Gross margin is gross profit as a percentage of revenue.

Interpace Biosciences's gross margin for the twelve months ending Jun 30, 2026 was 63.7%. For fiscal 2025 it was 62.3%, against 63.8% the year before. The highest annual figure on record is 229.4% in fiscal 2021.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202562.3%−1.5
FY2024Dec 31, 202463.8%+1.2
FY2023Dec 31, 202362.6%+5.3
FY2022Dec 31, 202257.3%−172.1
FY2021Dec 31, 2021229.4%+196.3
FY2020Dec 31, 202033.1%−1.3
FY2019Dec 31, 201934.4%−19.0
FY2018Dec 31, 201853.4%−0.3
FY2017Dec 31, 201753.7%+4.5
FY2016Dec 31, 201649.2%+22.5
FY2015Dec 31, 201526.7%+12.8
FY2014Dec 31, 201414.0%−2.1
FY2013Dec 31, 201316.0%−5.1
FY2012Dec 31, 201221.2%+0.5
FY2011Dec 31, 201120.6%+0.9
FY2010Dec 31, 201019.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202661.9%+4.8
Q1 FY2026Mar 31, 202665.4%+1.4
Q4 FY2025Dec 31, 202565.5%+1.8
Q3 FY2025Sep 30, 202562.1%−2.2
Q2 FY2025Jun 30, 202557.1%−7.7
Q1 FY2025Mar 31, 202564.0%+2.0
Q4 FY2024Dec 31, 202463.7%+1.4
Q3 FY2024Sep 30, 202464.3%+5.8
Q2 FY2024Jun 30, 202464.8%−0.5
Q1 FY2024Mar 31, 202462.0%−1.6
Q4 FY2023Dec 31, 202362.3%+43.2
Q3 FY2023Sep 30, 202358.5%−315.0
Q2 FY2023Jun 30, 202365.4%−130.4
Q1 FY2023Mar 31, 202363.6%−126.2
Q4 FY2022Dec 31, 202219.2%−9.7
Q3 FY2022Sep 30, 2022373.5%+318.4
Q2 FY2022Jun 30, 2022195.8%+147.8
Q1 FY2022Mar 31, 2022189.8%+143.9
Q4 FY2021Dec 31, 202128.9%−3.5
Q3 FY2021Sep 30, 202155.1%+18.0
Q2 FY2021Jun 30, 202148.0%+18.7
Q1 FY2021Mar 31, 202145.9%+13.4
Q4 FY2020Dec 31, 202032.4%+60.5
Q3 FY2020Sep 30, 202037.0%−0.4
Q2 FY2020Jun 30, 202029.3%−22.4
Q1 FY2020Mar 31, 202032.5%−23.9
Q4 FY2019Dec 31, 2019-28.1%−83.4
Q3 FY2019Sep 30, 201937.4%−14.6
Q2 FY2019Jun 30, 201951.7%−7.5
Q1 FY2019Mar 31, 201956.4%+10.0
Q4 FY2018Dec 31, 201855.3%−7.2
Q3 FY2018Sep 30, 201852.0%+1.2
Q2 FY2018Jun 30, 201859.2%+7.9
Q1 FY2018Mar 31, 201846.4%−2.6
Q4 FY2017Dec 31, 201762.5%+19.3
Q3 FY2017Sep 30, 201750.8%+6.4
Q2 FY2017Jun 30, 201751.3%–
Q1 FY2017Mar 31, 201749.0%–
Q4 FY2016Dec 31, 201643.1%–
Q3 FY2016Sep 30, 201644.3%–

More Interpace Biosciences figures

See a number that looks wrong?